key: cord-0986629-4ff2e17a
authors: Dost, Burhan; Kömürcü, Özgür; Bilgin, Sezgin; Dokmeci, Hilal; Terzi, Özlem; Baris, Sibel
title: Investigating the Effects of Protective Face Masks on the Respiratory Parameters of Children in the Post-Anesthesia Care Unit During the COVID-19 Pandemic
date: 2021-02-11
journal: J Perianesth Nurs
DOI: 10.1016/j.jopan.2021.02.004
sha: ad9300d732a6220141ec15bb206c07454992fb2c
doc_id: 986629
cord_uid: 4ff2e17a

Purpose The purpose of this study was to investigate the effect of protective face mask usage during the postoperative period on carbon dioxide retention in children during the COVID-19 pandemic. Design This study was designed as a prospective, randomized trial including 40 ASA I–II patients aged 3–10 years who were scheduled for elective surgery. Methods Patients were randomly allocated to two groups. The first group (Group 1) received O2 treatment over the protective face mask. In the second group (Group 2), the protective face mask was worn over the O2 delivery system. Heart rate (HR), oxygen saturation (SPO2) level, end-tidal carbon dioxide (EtCO2) level, and respiratory rate (RR) were measured using a patient monitor at 0, 5, 10, 15, 30, and 45 minutes and recorded. The primary outcome of the study was the determination of the EtCO2 levels, which were used to assess the safety of the mask in terms of potential carbon dioxide retention. Findings None of the participants’ SPO2 levels fell below 92% while wearing masks. There was no statistically significant difference between the groups in terms of EtCO2, HR, SPO2, and RR (p > 0.05). Conclusions During the COVID-19 pandemic, protective surgical face masks can be used safely in the postoperative period for pediatric patients aged 3–10 years.

This study was approved by the Medical Ethics Committee of Ondokuz Mayıs 57 University on October 08, 2020 (Approval no: 2020/572). Parental written informed consent 58 was obtained from all patients who participated in the study. 59

Individuals aged 3-10 years who were classified as American Society of 60

Anesthesiologists I-II pediatric elective surgery cases were included in the study (Figure 1 ). 61

Exclusion criteria included patients with emergency conditions, respiratory tract diseases, 62 complications that developed during the perioperative period, inability to tolerate the surgical 63 mask, and an oxygen saturation value (SpO 2 ) of < 92%. 64

The standard anesthesia protocol used in our clinic was applied to all patients. All 65 children were deprived of food for 6 h and water for 2 h before the surgery. Preoperative 66 sedation was not performed. Endotracheal intubation was performed after induction of 67 anesthesia with 4 mg/kg of propofol i.v. (intravenous) and 0.6 mg/kg of rocuronium 68 intravenously. Sevoflurane 2% combined with an oxygen-air mixture and 0.2 mcg/kg/min of 69 remifentanil infusion were used to maintain anesthesia. Neuromuscular blockade was 70 antagonized with 0.05 mg/kg neostigmine and 0.02 mg/kg atropine sulfate. Extubation was 71 performed after sufficient spontaneous respiration and return of protective reflexes. 72

Study randomization was performed on the day of the operation using a computer-73 generated randomization code. This randomization ID of each patient was delivered to the 74 anesthesiologist in a sealed envelope by an independent assistant. Follow-ups and 75 measurements of all patients in the study were performed by an anesthesia resident in the 76 recovery unit. All patients underwent preoperative real-time reverse transcriptase-polymerase 77 chain reaction tests (RT-PCR) for COVID-19, and negative cases were included in the study. 78 J o u r n a l P r e -p r o o f

To minimize variability, we provided participants with a 3-layer ultrasonic welding 79 disposable face mask with ear loops (Eliss children's mask, Ebrar Group Medical Textile, 80 Ankara, Turkey) and a monitor (Capnostream, Medtronic, Dublin, Ireland). The primary 81 outcome of the study was to assess changes in the levels of end-tidal carbon dioxide (EtCO 2 ) 82 induced by wearing the surgical facemask over or under the OxyMask™ during the 83 postoperative period. The secondary outcomes were heart rate (HR), SPO 2 level, and 84 respiratory rate (RR). 85

The OxyMask™ is a new face mask intended for oxygen delivery, which uses a small 86 "diffuser" to concentrate and direct oxygen toward the nose and mouth, thereby delivering 87 high concentrations of oxygen at a relatively low flow. At the same time, it has been shown to 88 have a high CO 2 clearance because of the open mask system. 9, 10 Given these advantages, the 89 OxyMask™ was preferred for supplemental oxygen therapy in our study. EtCO 2 was 90 measured from a carbon dioxide sample line attached to the OxyMask™. 91

In Group 1, immediately after the patients were extubated, a protective face mask was 92 placed and the patient was transferred to the PACU. In the PACU, 4 L/min O 2 treatment was 93 applied with an OxyMask™ (Southmedic Inc., Barrie, ON, Canada) over the face mask to the 94 patients in the recovery unit ( Figure 2 ). After the patients have arrived to the PACU, HR, 95 SPO 2 level, EtCO 2 level, and RR were measured, using a patient monitor, and recorded at 0, 96 5, 10, 15, 30, and 45 min. 97

In Group 2, 4 L/min O 2 treatment with the OxyMask™ was administered to patients in 98 the PACU. HR, SPO 2 , EtCO 2 , and RR were measured using the patient monitor and were 99 recorded at 0, 5, 10, 15, 30, and 45 min. A protective face mask was placed immediately after 100 the patients were extubated, over the OxyMask™, to prevent possible virus spread ( Figure 3) . 101

During the follow-up in the recovery unit, O 2 treatment was applied at 4 L/min to 102 prevent dilution of the EtCO 2 measurements and aerosolization from open areas of the 103 oxygen flow rate to 8 L/min in patients who developed hypoxia (SpO 2 < 92%). Patients with 105 apnea and desaturation were excluded from the study. 106

Sample size calculation was performed using Minitab (Version 16, Minitab, PA, 107 USA). Based on a similar previous study, 11 at a desired difference of 3 mmHg in EtCO 2 , a 108 power of 0.8, and a significance level of 0.05, a sample size of 14 participants was required 109 for each group. However, taking into account possible data loss, it was decided to include at 110 least 20 patients in each group. The data obtained were analyzed using SPSS software 111 (Version 22 for Windows, SPSS Inc., Chicago, IL, USA). While evaluating the data, 112 continuous variables were expressed as means ± standard deviations, and the frequency data 113 were expressed as numbers and percentages (%). Frequency data were compared using the 114 chi-square test. Data were tested for normality using the Shapiro-Wilk test. Differences 115 between intervention groups at baseline were assessed using independent t-tests for 116 continuous variables. A p value < 0.05 was considered statistically significant. For HR, SPO 2 , 117 EtCO 2 , and RR, two-way repeated-measures analyses of variance (RM-ANOVAs) were 118 performed, accounting for each group, measurement times (0, 5, 10, 15, 3, 45 min), and the 119 interaction term between group and measurement time. For pairwise comparisons in further 120 tests, a Bonferroni correction was applied, and the significance level was accepted as p < 121 0.01. 122 123

Forty patients were included in this study. The average age of the participants was 7.5 125 ± 2.2 years, 52.5% were male, and their body mass index (BMI) average was 21.7 ± 6.4 126 kg/m 2 . There was no statistically significant difference in age, sex, and BMI among the study 127 J o u r n a l P r e -p r o o f groups (p > 0.05) ( (Fig. 4A ). The effects of the group factor at 0-5 min ( p< 0.001) and 15-30 136 min were found to be very close to the significance level (p = 0.01) (Table 3) . However, there 137 was no significant difference between the groups in terms of the mean HR (F: 2.09, p = 0.15) 138 (Table 2) . 139

There was no statistically significant difference when SPO 2 measurements were tested 140 in terms of time variation (p = 0.054). Moreover, it was determined that there was no 141 significant difference between the groups in terms of mean SPO 2 values (p = 0.31, ) ( Table 2 ) 142 ( Fig. 4B) . 143

Mean EtCO 2 values were between 24.9 ± 3.6 and 20.5 ± 2.8 mmHg for Group 1 and 144 25.7 ± 4.5 and 16.4 ± 2.8 mmHg for Group 2 at 0 and 45 min, respectively. The changes in 145 mean EtCO 2 values at all time points (except 30-45 min) were statistically significant (Wilks' 146 Lambda: 0.12, F: 46.6, p < 0.001). There was a trend for a decrease (Fig. 4C) . The group 147 factor also had an effect on the temporal change in EtCO 2 (Wilks' Lambda: 0.54, F: 5.6, p = 148 0.001) ( Table 2 ). According to the Bonferronni correction, the effect of the group variable on 149 time was close to the limit of significance at 15-30 min and 30-45 min (p = 0.03, p = 0.02, 150 respectively), while it was not significant at other time intervals (p > 0.01) ( Table 3) . 151

However, there was no significant difference between the groups in terms of EtCO 2 means (p 152 = 0.14) ( Table 2) . 153

There was a statistically significant difference (p < 0.001) when the RR measurements 154

were assessed in terms of time variation, but the group variable did not influence this time 155 variation (p = 0.11). There was also no difference between the groups (p = 0.72) ( Table 2) In this study, we found that the use of a protective face mask under or over the 162 OxyMask TM in the PACU did not affect EtCO2, SpO2, RR, and HR. In addition, these values 163 were within normal limits for the pediatric age group. Although there was no difference in 164 Children tend to retain carbon dioxide more than adults due to a higher dead space/tidal 203 volume ratio and increased airway resistance because of secretions in the postoperative 204 period. 23 Therefore, the use of masks in children will make these clinical changes more FiO2 values in adults. 6 Similarly, in this study, we showed that wearing a face mask over or 212 under a supplemental oxygen mask did not cause significant changes in respiratory and 213 hemodynamic parameters during the postoperative period in pediatric patients. 214

One of the limitations of this study is that we had to use protective masks for all 215 groups because the possibility of COVID-19 could not be completely excluded by Since this study was performed during the pandemic period, we did not choose the option of 217 not wearing protective masks for patient and employee safety concerns. Second, we observed 218 changes in healthy children without respiratory problems, but in future, studies should be 219 performed in younger age groups and in children with respiratory problems. 220 221

We have shown that the use of protective surgical face masks in pediatric patients does 223 not cause negative changes in respiratory and hemodynamic parameters during the early 224 20. Roberge 13.6 (0.001***) HR, heart rate; SpO 2 , oxygen saturation; EtCO 2 , end-tidal carbon dioxide; RR, respiratory rate. The time intervals of the measurements were evaluated using repeated measures analysis of variance. Bonferroni correction was applied for advanced statistics. * Time effect ** Time × group effect

Consensus 229 guidelines for managing the airway in patients with COVID-19

Pediatric Anesthesia 232 Advisory: What should we know as a pediatric anesthetist when a COVID-19 patient 233 needs an operation?

Peripheral Oxygen Saturation in Older Persons Wearing 237 Nonmedical Face Masks in Community Settings

Respiratory complications in the postanesthesia care unit: A 239 review of pathophysiological mechanisms

Oxygen: under or over a surgical facemask for 241 COVID-19 patients?

Adverse respiratory events in 243 anesthesia: a closed claims analysis

Incidence and risk 245 factors of perioperative respiratory adverse events in children undergoing elective 246 surgery

Comparison of the OxyMask and Venturi mask in the delivery 248 of supplemental oxygen: pilot study in oxygen-dependent patients

A randomised clinical trial to 253 evaluate the safety, fit, comfort of a novel N95 mask in children

Capnographic Analysis of 256 Minimum Mandatory Flow Rate for Hudson Face Mask: A Randomized Double

Critically ill patients with severe acute 259 respiratory syndrome

Airflows around oxygen masks: A potential source of 261 infection?

Evidence-Based Approach for Optimization of Infection Control and Operating Room 264 Management

Role of Anesthesia Nurses in the Treatment and 266 Management of Patients With COVID-19

Plethysmographic measurements of specific airway 269 resistance in young children

Physiologic effects and measurement of carbon dioxide and 271 oxygen levels during qualitative respirator fit testing

Physiological impact of the 274 N95 filtering facepiece respirator on healthcare workers

ASA, American Society of Anesthesiologists; BMI, body mass index.J o u r n a l P r e -p r o o f